# 贝瑞基因 / 响应式官网设计 - ID: 1 - URL: https://www.stoyard.com/works/1 - English URL: https://www.stoyard.com/en/works/1 - Year: 2018 - Cover: https://static.glabcms.stoyard.com/stoyard/project/cover/20241230/zmbjtacpqlj.jpg - Categories: 上市公司, 大型品牌官网定制, 医疗仪器，医药健康 - English Categories: Listed Company, Office Website SOLUTION, Biotech,Healthcare - Author: STOYARD - English Author: STOYARD - Publish: 2020-04-13 - Editor: STOYARD BEIJING ## 中文主体 ### 项目简介 北京贝瑞和康生物技术有限公司成立于2010年5月，是致力于应用高通量基因测序技术，为生命科学研究和临床医学疾病筛查和诊断提供“无创式”整体解决方案的研发型生物科技公司，是将基因测序技术实现科学研究和临床转化的行业践行者。贝瑞基因的研发团队由高扬博士与曾经参与高通量测序仪设计和研发的周代星博士带队，由高通量测序领域和临床基因检测领域内顶尖的实验、研发、生物信息分析专家组成，并与领域内全球知名的研究机构建立了合作关系。公司先后于2011年9月获得中关村高新技术企业认证，2012年12月获得国家高新技术企业认证，2017年8月成功登陆A股主板上市。      ## English Content ### Introduction Beijing Beiruihekang Biotech Co., Ltd. was founded in May 2010, which is a research and development biotechnology company dedicated to the application of high-throughput gene sequencing technology to provide a "non-invasive" integrated solution for life science research and clinical medicine disease screening and diagnosis. Practitioners. Led by Dr. Yang Gao and Dr. Daixing Zhou, who was once involved in the design and development of high-throughput sequencing instrument, the research and development team of Berry Gene is composed of leading experts in experiments, R&D and bioinformatics analysis in the field of high-throughput sequencing and clinical genetic testing, and has established cooperation with world-renowned research institutions in the field. The company has obtained Zhongguancun High-Tech Enterprise certification in September 2011, National High-Tech Enterprise certification in December 2012, and successfully listed on the A-share Main Board in August 2017.     